{"changes":[],"country":"FR","description":"Tiakis Biotech develops therapies that boost the body's own protective mechanisms in pulmonary arterial hypertension and post-surgical inflammation. It targets PAH patients and people undergoing highly invasive surgery at risk of inflammatory complications. Partnerships with Stanford and Edinburgh anchor a preventive, mechanism-driven approach rather than symptom management.","domain":"tiakis.bio","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"health","investors":[],"lat":54.315193,"lng":10.130499,"location":"Kiel, Germany","name":"Tiakis Biotech","rounds":[{"amountQuarantined":false,"amountUsd":2700000,"currency":"EUR","date":"2025-09-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-08","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"tiakis-bio","sources":[{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-08","status":"attributed","url":null},{"fact":"existence","publisher":"tiakis.bio","retrievedAt":"2026-05-08","status":"self-reported","url":"https://tiakis.bio"},{"fact":"description","publisher":"tiakis.bio","retrievedAt":"2026-05-08","status":"self-reported","url":"https://tiakis.bio"}],"stage":null,"techStack":["Apache HTTP Server","apache"],"totalRaisedUsd":2700000,"updatedAt":"2026-05-08"}